Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: FDA facilities consolidation

This article was originally published in The Tan Sheet

Executive Summary

FDA facilities consolidation: Members of the Maryland congressional delegation urge the General Services Administration to consider the 700-acre White Oak naval facility as a site for a new FDA campus. In a June 23 letter to GSA Administrator Roger Johnson, Democratic Sens. Barbara Mikulski and Paul Sarbanes and Reps. Constance Morella (R) and Albert Wynn (D) pointed to the White Oak infrastructure and proximity to local research centers as incentives. The Greenbelt, Md.-based architectural and engineering firm of Greenhorn and O'Mara is currently assessing clean up of the site, which contains waste dumps and other environmental hazards...

FDA facilities consolidation: Members of the Maryland congressional delegation urge the General Services Administration to consider the 700-acre White Oak naval facility as a site for a new FDA campus. In a June 23 letter to GSA Administrator Roger Johnson, Democratic Sens. Barbara Mikulski and Paul Sarbanes and Reps. Constance Morella (R) and Albert Wynn (D) pointed to the White Oak infrastructure and proximity to local research centers as incentives. The Greenbelt, Md.-based architectural and engineering firm of Greenhorn and O'Mara is currently assessing clean up of the site, which contains waste dumps and other environmental hazards....

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS083989

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel